Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

LYL1 gene amplification predicts poor survival of patients with uterine corpus endometrial carcinoma: analysis of the Cancer genome atlas data.

BMC cancer - 2 May 2018

Kim Se Ik, Lee Ji Won, Lee Nara, Lee Maria, Kim Hee Seung, Chung Hyun Hoon, Kim Jae-Weon, Park Noh Hyun, Song Yong-Sang, Seo Jeong-Sun

Abstract excerpt

BACKGROUND: Somatic amplifications of the LYL1 gene are relatively common occurrences in patients who develop uterine corpus endometrial carcinoma (UCEC) as opposed to other cancers. This study was undertaken to determine whether such genetic alterations affect survival outcomes of UCEC. METHODS: In 370 patients with UCEC, we analysed clinicopathologic characteristics and corresponding genomic data from The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Basic Helix-Loop-Helix Transcription Factors
Share to Comorbidity

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Copy Number Variations

Share to Endometrial Neoplasms

Share to Gene Amplification

Share to Neoplasm Grading

Share to Neoplasm Proteins

Share to Neoplasm Staging

Source

Open in PubMed Open full text

Identifiers

PMID: 29716549
DOI: 10.1186/s12885-018-4429-z
PMCID: PMC5930686

Genes

LYL1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

LYL1 gene amplification predicts poor survival of patients with uterine corpus endometrial carcinoma: analysis of the Cancer genome atlas data.PMID 29716549Read ↗

COL1A1, ITGB1, THY1, and PDGFRA: key immune-related genes in uterine corpus endometrial carcinoma with prognostic and therapeutic implicationsSemantic proximity Read ↗

A recurrent endometrial stromal sarcoma harbors the novel fusion JAZF1-BCORL1Semantic proximity Read ↗

Clinicopathological and genomic characterization of BCORL1-driven high-grade endometrial stromal sarcomas.Semantic proximity Read ↗

Amplification of 1q32.1 Refines the Molecular Classification of Endometrial CarcinomaSemantic proximity Read ↗

Prognostic biomarker GOLM1 correlated with immune infiltrates in Endometrial cancerSemantic proximity Read ↗

Molecular Subtypes of Uterine Leiomyosarcoma and Correlation with Clinical OutcomeSemantic proximity Read ↗

Expression and prognostic value of EGF-like domain multiple 6 in uterine corpus endometrial carcinoma and its correlation with immune cell infiltrationSemantic proximity Read ↗

Depleted-MLH1 Expression Predicts Prognosis and Immunotherapeutic Efficacy in Uterine Corpus Endometrial Cancer: An In Silico ApproachSemantic proximity Read ↗

LHX1 as a potential biomarker regulates EMT induction and cellular behaviors in uterine corpus endometrial carcinomaSemantic proximity Read ↗

MCM10 : An effective treatment target and a prognostic biomarker in patients with uterine corpus endometrial carcinomaSemantic proximity Read ↗

Low Expression of RILPL2 Predicts Poor Prognosis and Correlates with Immune Infiltration in Endometrial CarcinomaSemantic proximity Read ↗

Comprehensive analyses of telomerase component DKC1 and its association with clinical, molecular and immune landscapes in uterine corpus endometrial carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.